Telemis, the specialist in PACS, digital pathology and healthcare Business Intelligence, closes its 2022-2023 financial year with growth.

 

 

Telemis, the specialist in PACS, digital pathology and healthcare Business Intelligence, closes its 2022-2023 financial year with growth.

 

Louvain-la-Neuve, (Belgium), 31 August 2023

 

Telemis, the specialist in PACS, digital pathology and healthcare Business Intelligence, closes its 2022-2023 financial year with growth.

The company recorded a turnover of €11,031,516. For the twenty-first consecutive year, it also announced a profit of €1,666,371.

 

Over the course of 2022-2023, Telemis has seen significant developments in its various solutions.

 

Several new healthcare sites chose to equip themselves with Telemis PACS/MACS solutions, including the CH GUEBWILLER (France), le CHU Tivoli (Belgium), and the RISF (France).

 

The TM-Microscopy digital pathology solution has seen significant growth, thanks in particular to its first references in France. 

The rapid adoption of this solution by healthcare professionals testifies to its effectiveness in the field of pathology and its advantages for pathologists.

 

Many healthcare establishments have adopted the Intuitus hospital cockpit solution, initially used to manage imaging services.

Its expansion into dashboards for operating rooms and analysis laboratories demonstrates its usefulness and its ability to provide objective information by cross-referencing different data sources.

 

Telemis also marked this period by its strategic partnership with Incepto, an AI solutions platform applied to medical imaging. 

This unique collaboration combines Telemis' expertise in PACS/MACS with the cutting-edge AI capabilities of Incepto and its partners.

 

Finally, throughout the year, Telemis took part in numerous international congresses in Germany, Belgium, France, Italy, Switzerland, Luxembourg and the United States. 

These events provide a valuable opportunity to meet the users of our solutions and to listen to the needs of the constantly evolving medical industry.

 

The CEO of the Telemis Group, Stephane Ketelaer, expressed his satisfaction with this year's results: "We are delighted to see that the entire range of Telemis solutions continues to progress. I'm even more impressed by the fact that we've been able to see so many of our users again at the various congresses and that we've been able to relaunch activities such as the User Groups. There's nothing like being in touch with the users of our solutions."